| EGOM, Emmanuel Eroume-A., Rebabonye B. PHARITHI, Soressa HESSE, Neasa STARR, Richard ARMSTRONG, Habitha Mohammed SULAIMAN, Katarina GAZDIKOVA, Ioana MOZOS, Martin CAPRNDA, Peter KUBATKA, Peter KRUŽLIAK, Barkat KHAN, Ludovit GASPAR a Vincent M. G. MAHER. Latest Updates on Lipid Management. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. NORTHCOTE: ADIS INT LTD, 2019, roč. 26, č. 2, s. 85-100. ISSN 1120-9879. Dostupné z: https://dx.doi.org/10.1007/s40292-019-00306-8. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1545968,
author = {Egom, Emmanuel EroumeandA. and Pharithi, Rebabonye B. and Hesse, Soressa and Starr, Neasa and Armstrong, Richard and Sulaiman, Habitha Mohammed and Gazdikova, Katarina and Mozos, Ioana and Caprnda, Martin and Kubatka, Peter and Kružliak, Peter and Khan, Barkat and Gaspar, Ludovit and Maher, Vincent M. G.},
article_location = {NORTHCOTE},
article_number = {2},
doi = {http://dx.doi.org/10.1007/s40292-019-00306-8},
keywords = {ASCVD; Atherosclerotic cardiovascular disease; Cholesterol; Lipid management; Triglycerides},
language = {eng},
issn = {1120-9879},
journal = {HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION},
title = {Latest Updates on Lipid Management},
url = {http://dx.doi.org/10.1007/s40292-019-00306-8},
volume = {26},
year = {2019}
}
TY - JOUR
ID - 1545968
AU - Egom, Emmanuel Eroume-A. - Pharithi, Rebabonye B. - Hesse, Soressa - Starr, Neasa - Armstrong, Richard - Sulaiman, Habitha Mohammed - Gazdikova, Katarina - Mozos, Ioana - Caprnda, Martin - Kubatka, Peter - Kružliak, Peter - Khan, Barkat - Gaspar, Ludovit - Maher, Vincent M. G.
PY - 2019
TI - Latest Updates on Lipid Management
JF - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
VL - 26
IS - 2
SP - 85-100
EP - 85-100
PB - ADIS INT LTD
SN - 11209879
KW - ASCVD
KW - Atherosclerotic cardiovascular disease
KW - Cholesterol
KW - Lipid management
KW - Triglycerides
UR - http://dx.doi.org/10.1007/s40292-019-00306-8
L2 - http://dx.doi.org/10.1007/s40292-019-00306-8
N2 - Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.
ER -
EGOM, Emmanuel Eroume-A., Rebabonye B. PHARITHI, Soressa HESSE, Neasa STARR, Richard ARMSTRONG, Habitha Mohammed SULAIMAN, Katarina GAZDIKOVA, Ioana MOZOS, Martin CAPRNDA, Peter KUBATKA, Peter KRUŽLIAK, Barkat KHAN, Ludovit GASPAR a Vincent M. G. MAHER. Latest Updates on Lipid Management. \textit{HIGH BLOOD PRESSURE \&{}amp; CARDIOVASCULAR PREVENTION}. NORTHCOTE: ADIS INT LTD, 2019, roč.~26, č.~2, s.~85-100. ISSN~1120-9879. Dostupné z: https://dx.doi.org/10.1007/s40292-019-00306-8.
|
